September 17, 2025
Phapros Disburses UMK Funding Program Totaling IDR 2.912 Billion as of September 2025
PT Phapros Tbk, a national pharmaceutical company, once again demonstrates its commitment to supporting the growth of Micro, Small, and Medium Enterprises (UMKM) by distributing partnership funds amounting to IDR 2.9 billion as of September 2025 ...
See More
August 12, 2025
Drive Revenue Growth, Phapros Accelerates Exports in 2025
The expansion is carried out by exporting its flagship products to Timor Leste and Cambodia in the second half of 2025. ...
See More
July 28, 2025
Sales Increased by 25% in the Second Half of 2025, Phapros Achieves 869% EBITDA Growth
Phapros' recorded a 25 percent year-on-year increase in consolidated sales growth for the first half of 2025. ...
See More
July 13, 2025
Phapros (PEHA) Holds Plogging Event to Commemorate Indonesia's 80th Independence Day: Realizing the Spirit of Independence with a Clean Environment
Phapros' celebrated Indonesia's 80th Independence Day by holding a community environmental care event through Plogging Day....
See More
June 21, 2025
Phapros (PEHA) Commemorates Its 71st Anniversary with a Fun Walk and Catfish Stocking in Banjir Kanal Barat, Semarang
PT Phapros Tbk., a national pharmaceutical company, celebrates its 71st anniversary by organizing a fun walk and catfish stocking in Banjir Kanal Barat...
See More
May 30, 2025
Successful Marketing Transformation Step Boosts PEHA Sales by 79% in Q1/2025 for Over-the-Counter (OTC) Medications
Phapros' successfully recorded a 79% year-on-year (YoY) sales growth in the over-the-counter (OTC) segment...
See More